FDA Panel Supports Omicron-specific Boosters Despite Lack of Safety, Efficacy Data; Biden Places $3.2B Order With Pfizer
By Veronika Kyrylenko Article Source According to a common saying, “Insanity is doing the same thing over and over again and expecting different results.” When it comes to the coronavirus vaccines, it has become clear that they...
Read More